HES 130-0.4: Clinical Trials

3 trials of HES 130-0.4, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow HES 130-0.4: new trials by email Literature Review of HES 130-0.4 trials Research Report on HES 130-0.4

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Colloid Pre-Loading on D-Dimer During Cesarean Section Under Spinal Anesthesia
hydroxyethyl starch (6% 130/0.4), Hyperbaric bupivacaine, Morphine - Coagulation Defect; Bleeding
Phase 2CompletedAssiut University602016-01-012016-11-08
Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia
Hemospan (MP4OX), Voluven (HES 130/0.4) - Vascular Disease, Critical Lower Limb Ischemia
Phase 2CompletedSangart62007-09-012013-08-19
Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization
Percutaneous Coronary Revascularization, Hemoglobin-Based Oxygen Carrier-201 (HBOC-201), Voluven - Angina Pectoris, Unstable Angina
Phase 2CompletedBiopure Corporation452003-12-012008-05-16

Conditions studied

Angina Pectoris (1)  ·  Angina, Unstable (1)  ·  Hemorrhage (1)  ·  Hemostatic Disorders (1)  ·  Hypotension (1)  ·  Ischemia (1)  ·  Myocardial Infarction (1)  ·  Vascular Diseases (1)

Sponsors

Assiut University (1)  ·  Biopure Corporation (1)  ·  Sangart (1)

Countries

Belgium (1)  ·  Egypt (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Sweden (1)

Top investigators

P W Serruys, Professor (1)

Results publications

PMID 19608488